Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Loading...
Community
/
Switzerland
/
Pharmaceuticals & Biotech
/
PolyPeptide Group
Create a narrative
PolyPeptide Group Community
SWX:PPGN Community
1
Narratives
written by author
0
Comments
on narratives written by author
4
Fair Values set
on narratives written by author
Community Investing Ideas
PolyPeptide Group
Popular
Undervalued
Overvalued
PolyPeptide Group
PK
PKU
Community Contributor
Biotech longerterm bet
211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.
View narrative
CHF 33.1
FV
21.1% undervalued
intrinsic discount
11.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 1 year ago
author updated this narrative